Agents and Actions

, Volume 26, Issue 3–4, pp 335–341 | Cite as

Edema and cell infiltration in the phorbol ester-treated mouse ear are temporally separate and can be differentially modulated by pharmacologic agents

  • L. M. De Young
  • J. B. Kheifets
  • S. J. Ballaron
  • J. M. Young
Inflammation and Immunomodulation


The temporal patterns of edema and accumulation of the PMN marker enzyme, myeloperoxidase (MPO), were examined following application of tetradecanoylphorbol acetate (TPA) to mouse ears. After application of 2.5 μg TPA, edema peaked at 6 hr, while MPO activity peaked at 24 hr. Pharmacological agents with defined mechanisms of action, delivered orally or topically, were assessed for effects on these responses. For oral administration, compounds were delivered 1 hr before and 6 hr after TPA and for topical administration compounds were delivered at 15 min and 6 hr after TPA. Topical and oral corticosteroids inhibited both edema and MPO accumulation. Cyclooxygenase and lipoxygenase inhibitors were very effective against MPO accumulation but were either inactive or moderately active vs edema. Anti-histamine/anti-serotonin agents had little effect on edema, but could inhibit or exacerbate MPO accumulation depending on dose and route of administration. Topically applied histamine itself did not effect TPA-induced edema, but markedly suppressed MPO accumulation. Acetone, the vehicle, when topically applied between 0.5 and 2 hr after TPA inhibited MPO accumulation by 60–80%, but had little effect on edema. Acetone applied before 0.5 hr or after 2 hr had no effect on either parameter. These results indicate that in the TPA-induced ear inflammation model the MPO response at 24 hr may be a useful additional indicator of drug activity.


Corticosteroid Histamine Temporal Pattern Drug Activity Cell Infiltration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    R. P. Carlson, L. O'Neill-Davis, J. Chang and A. J. Lewis,Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacological agents. Agents and Actions17, 197–204 (1985).CrossRefPubMedGoogle Scholar
  2. [2]
    J. M. Young, B. M. Wagner and D. A. Spires,Tachyphylaxis in 12-O-tetradecanoylphorbolacetate- and arachidonic acid-induced ear edema. J. Invest. Dermatol.80, 48–52 (1983).CrossRefPubMedGoogle Scholar
  3. [3]
    P. P. Bradley, D. A. Priebat, R. D. Christensen and G. Rothstein,Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol.78, 206–209 (1982).CrossRefPubMedGoogle Scholar
  4. [4]
    P. J. Bailey and A. Sturm,Immune complexes and inflammation: The reverse passive arthus reaction in the rat. Biochem. Pharmacol.32, 475–481 (1983).CrossRefPubMedGoogle Scholar
  5. [5]
    L. M. De Young, D. A. Spires, J. Kheifets and T. G. Terrell,Biology and pharmacology of recombinant human interleukin-1 B-induced rat ear inflammation. Agents and Actions21, 325–327 (1987).CrossRefPubMedGoogle Scholar
  6. [6]
    K. Suzuki, H. Ota, S. Sasagawa, T. Sakatani and T. Fukikura,Assay method for myeloperoxidase in polymorphonuclear leucocytes. Anal. Biochem.132, 345–352 (1983).CrossRefPubMedGoogle Scholar
  7. [7]
    D. V. Krishnamurthy, M. Kruseman-Aretz, S. Rouhafza-Fard, C. J. Bedord, J. M. Young, G. Jones and M. Venuti,Selective inhibition of arachidonic acid 5-lipoxygenase by a novel antipsoriatic agent, 6-chloro-1,4-diacetoxy-2,3-dimethoxy-naphthalene (RS-43179). Fed. Proc.44, 886 (1985).Google Scholar
  8. [8]
    D. S. Fletcher, D. Osinga and R. J. Bonney,Role of polymorphonuclear leucocytes in connective tissue breakdwon during the reverse passive arthus reaction. Biochem. Pharmacol.35, 2602–2606 (1986).CrossRefGoogle Scholar
  9. [9]
    M. S. Koh, L. Parente and D. A. Willoughby,Immunological and non-immunological pleural inflammation: The effects of anti-inflammatory and anti-rheumatic drugs. Eur. J. Rheum. Inflammation1, 286–290 (1979).Google Scholar
  10. [10]
    A. C. Issekutz, M. Szpejda and M. Ripley,Effects of lipoxygenase and cyclooxygenase inhibitors on neutrophil margination, emigration, and related inflammatory responses. InAdvances in Inflammation Research, vol. 11. (Ed. I. Otterness et al.) pp. 31–45, Raven Press, New York 1986.Google Scholar
  11. [11]
    M. E. Cantwell and J. C. Foreman,Phorbol esters induce a slow, non-cytotoxic release of histamine from rat peritoneal mast cells. Agents and Actions20, 165–168 (1987).PubMedGoogle Scholar
  12. [12]
    K. Ohuchi, M. Watanabe, C. Takahashi, Y. Hayashi, N. Hirasawa, S. Tsurufuji, H. Fujiki and T. Sugimura,Analysis of tumor-promoter-induced inflammation in rats: participation of histamine and prostaglandin E 2. Biochim. Biophys. Acta925, 156–163 (1987).PubMedGoogle Scholar
  13. [13]
    L. G. Garland, A. F. Green and H. F. Hodson,Inhibitors of the release of anaphylactic mediators. In Anti-Inflammatory Drugs. (Ed. J. R. Vane and S. H. Ferreira) p. 515, Springer, New York 1979.Google Scholar

Copyright information

© Birkhäuser Verlag 1989

Authors and Affiliations

  • L. M. De Young
    • 1
  • J. B. Kheifets
    • 1
  • S. J. Ballaron
    • 1
  • J. M. Young
    • 1
  1. 1.Department of Inflammation BiologySyntex ResearchPalo AltoUSA

Personalised recommendations